RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $16,478,000 | +2.3% | 343,215 | 0.0% | 0.01% | +50.0% |
| Q4 2019 | $16,107,000 | +96.1% | 343,215 | -1.2% | 0.01% | +100.0% |
| Q3 2019 | $8,212,000 | -23.5% | 347,239 | -2.7% | 0.00% | -25.0% |
| Q2 2019 | $10,731,000 | +28.1% | 356,854 | -4.6% | 0.00% | +33.3% |
| Q1 2019 | $8,379,000 | +13.4% | 374,073 | -7.9% | 0.00% | 0.0% |
| Q4 2018 | $7,391,000 | +3.6% | 406,120 | +3.0% | 0.00% | 0.0% |
| Q3 2018 | $7,131,000 | +234.0% | 394,179 | +83.7% | 0.00% | +200.0% |
| Q2 2018 | $2,135,000 | +138.8% | 214,579 | +27.4% | 0.00% | – |
| Q1 2018 | $894,000 | +141.0% | 168,453 | +285.4% | 0.00% | – |
| Q4 2017 | $371,000 | – | 43,703 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $294,724,000 | 15.40% |
| RA Capital Management | 4,858,260 | $233,245,000 | 7.37% |
| HAVENS ADVISORS LLC | 143,266 | $6,878,000 | 6.70% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 609,614 | $29,267,000 | 6.40% |
| OMNI PARTNERS LLP | 1,052,744 | $50,542,000 | 4.45% |
| HBK INVESTMENTS L P | 2,004,042 | $96,214,000 | 4.03% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,005,600 | $96,289,000 | 3.83% |
| Versor Investments LP | 1,108,845 | $53,236,000 | 3.53% |
| OXFORD ASSET MANAGEMENT LLP | 461,016 | $22,133,000 | 3.12% |
| HighVista Strategies LLC | 63,222 | $3,035,000 | 2.81% |